Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07129538

Outcomes of Inspiratory Muscle Training in FMF Adolescents

Familial mediterranean fever (FMF) is common to be diagnosed before age of 18 . this disorder is connected with deterioration in exercise tolerance, pulmonary capacities, fatigue tolerance,

Recruiting

Interested in participating?

Request Info

Key information

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Familial mediterranean fever (FMF adolescents ) will be collected to be cateogarized to inspiratory muscle retraining group (IMR group) or control waitlist grouping. every group OF FMF will contain 20 FMF adolescents. IMR group will receive two IMR sessions daily, five times weekly, for eight weeks (every IMR session will contain 3 sets of IMR and the set will contain 10 breath cycles).. both groups will receive their prescribed colchicine medications daily

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • FMF adolecents
  • ages 13 -17 years
  • forty patients

Exclusion criteria

  • cardiac problems
  • renal problems
  • liver problems
  • diabetes
  • brain problems

Treatment and study plan

inspiratory muscle retraining

Other

Familial mediterranean fever (FMF adolescents ) will be inspiratory muscle retraining group (IMR group) that will contain 20 FMF adolescents. IMR group will receive two IMR sessions daily, five times weekly, for eight weeks (every IMR session will contain 3 sets of IMR and the set will contain 10 breath cycles).. this group will receive their prescribed colchicine medications daily

colchicine only

Other

Familial mediterranean fever (FMF adolescents ) will be collected in this group OF FMF that will contain 20 FMF adolescents. this group will receive their prescribed colchicine medications daily for eight weeks

Primary outcomes

  1. Multidimensional Scale of Fatigue extracted from total score of pediatric quality of life

    Time frame: it will be measured after 8 weeks

    it will assess fatigue perception

Secondary outcomes

  1. cognitive fatigue subscale of Multidimensional Scale of Fatigue related pediatric quality of life

    Time frame: it will be measured after 8 weeks

    it will assess cognitive fatigue perception

  2. sleep and rest fatigue subscale of Multidimensional Scale of Fatigue related pediatric quality of life

    Time frame: it will be measured after 8 weeks

    it will assess fatigue perception during sleep and rest

  3. general fatigue subscale of Multidimensional Scale of Fatigue related pediatric quality of life

    Time frame: it will be measured after 8 weeks

    it will assess general fatigue perception

  4. six minute walk distance

    Time frame: it will be measured after 8 weeks

    it will assess distance covered by FMF patients in six minutes of ongoing walking

  5. Forced vital capacity

    Time frame: it will be measured after 8 weeks

    it is a pulmonary capacity test

  6. Forced exhalation volume (at first second of exhalation)

    Time frame: it will be measured after 8 weeks

    it is a pulmonary function testing

  7. Ration of Forced exhalation volume (at first second of exhalation) to forced exhalation capacity

    Time frame: it will be measured after 8 weeks

    it is a pulmonary function testing

  8. maximum inhalation pressure

    Time frame: it will be measured after 8 weeks

    it is indicator for inspiratory muscular strength

  9. physical sum of child health qestionnaire

    Time frame: it will be measured after 8 weeks

    it is an indiactor for physical quality of life

  10. mental sum of child health qestionnaire

    Time frame: it will be measured after 8 weeks

    it is an indiactor for mental quality of life

Study contacts

Contact information is provided by the study sponsor or research team.

Ali MA Ismail, lecturer

CONTACT

[email protected]

01005154209

Ismail, lecturer

CONTACT

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 19, 2025
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.